Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Meike-Kristin Abraham"'
Autor:
Meike-Kristin Abraham, Elena Jost, Jan David Hohmann, Amy Kate Searle, Viktoria Bongcaron, Yuyang Song, Hans Peter Wendel, Karlheinz Peter, Stefanie Krajewski, Xiaowei Wang
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1504 (2021)
Medical devices directly exposed to blood are commonly used to treat cardiovascular diseases. However, these devices are associated with inflammatory reactions leading to delayed healing, rejection of foreign material or device-associated thrombus fo
Externí odkaz:
https://doaj.org/article/88777bf763c04488bacd0ea6dfaeca3d
Autor:
Tatjana Michel, Daniel Luft, Meike-Kristin Abraham, Sabrina Reinhardt, Martha L. Salinas Medina, Julia Kurz, Martin Schaller, Meltem Avci-Adali, Christian Schlensak, Karlheinz Peter, Hans Peter Wendel, Xiaowei Wang, Stefanie Krajewski
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss , Pp 459-468 (2017)
Synthetically modified mRNA is a unique bioactive agent, ideal for use in therapeutic applications, such as cancer vaccination or treatment of single-gene disorders. In order to facilitate mRNA transfections for future therapeutic applications, there
Externí odkaz:
https://doaj.org/article/bc4a700ea9284023bb3ab42a8e94a9b0
Autor:
Meike-Kristin Abraham, Andrea Nolte, Rebekka Reus, Andreas Behring, Diane Zengerle, Meltem Avci-Adali, Jan David Hohmann, Karlheinz Peter, Christian Schlensak, Hans Peter Wendel, Stefanie Krajewski
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0138375 (2015)
Stent angioplasty provides a minimally invasive treatment for atherosclerotic vessels. However, no treatment option for atherosclerosis-associated endothelial dysfunction, which is accompanied by a loss of CD39, is available, and hence, adverse effec
Externí odkaz:
https://doaj.org/article/577d3f858bd8479582069072beef4acf
Autor:
Jan David Hohmann, Karlheinz Peter, Stefanie Krajewski, Amy Kate Searle, Meike-Kristin Abraham, Elena Jost, Viktoria Bongcaron, Hans Peter Wendel, Yuyang Song, Xiaowei Wang
Publikováno v:
Pharmaceutics, Vol 13, Iss 1504, p 1504 (2021)
Pharmaceutics
Volume 13
Issue 9
Pharmaceutics
Volume 13
Issue 9
Medical devices directly exposed to blood are commonly used to treat cardiovascular diseases. However, these devices are associated with inflammatory reactions leading to delayed healing, rejection of foreign material or device-associated thrombus fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ed8694b3827b3a080e56e5715694ad0
https://www.mdpi.com/1999-4923/13/9/1504
https://www.mdpi.com/1999-4923/13/9/1504
Autor:
Eefang Yu, Bock Lim, Jan David Hohmann, Ao Leo Liu, Maria Wallert, Karlheinz Peter, Yung-Chih Chen, Yu Yao, Xiaowei Wang, Meike-Kristin Abraham, Amy Kate Searle, Jathushan Palasubramaniam
Publikováno v:
Molecular Therapy
Abdominal aortic aneurysm (AAA) is an often deadly disease without medical, non-invasive treatment options. The upregulation of vascular cell adhesion molecule-1 (VCAM-1) on aortic endothelium provides an early target epitope for a novel biotechnolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb20d1f78d196555e671dc2970c461a
https://doi.org/10.1016/j.ymthe.2018.02.010
https://doi.org/10.1016/j.ymthe.2018.02.010
Autor:
Julia Kurz, Stefanie Krajewski, Karlheinz Peter, Martin Schaller, Martha L. Salinas Medina, Hans Peter Wendel, Sabrina Reinhardt, Meltem Avci-Adali, Christian Schlensak, Meike Kristin Abraham, Xiaowei Wang, Daniel Luft, Tatjana Michel
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss, Pp 459-468 (2017)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Synthetically modified mRNA is a unique bioactive agent, ideal for use in therapeutic applications, such as cancer vaccination or treatment of single-gene disorders. In order to facilitate mRNA transfections for future therapeutic applications, there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6d80e4f6ebaa3687ccaa2a3557f8d3
http://www.sciencedirect.com/science/article/pii/S216225311730224X
http://www.sciencedirect.com/science/article/pii/S216225311730224X
Autor:
Karlheinz Peter, Tatjana Michel, Stefanie Krajewski, Hans Peter Wendel, Xiaowei Wang, Meike-Kristin Abraham
Publikováno v:
Nanotheranostics
Rationale: Genetic therapy using modified mRNA for specific therapeutic protein expression for disease treatment and vaccination represents a new field of therapeutic and diagnostic medicine. Non-viral vectors transfection using biocompatible nanolip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692104b2655ab085b841489750c9e176
https://doi.org/10.7150/ntno.19449
https://doi.org/10.7150/ntno.19449
Autor:
Tatjana, Michel, Antonia, Link, Meike-Kristin, Abraham, Christian, Schlensak, Karlheinz, Peter, Hans-Peter, Wendel, Xiaowei, Wang, Stefanie, Krajewski
Publikováno v:
Journal of visualized experiments : JoVE. (144)
The development of messenger RNA (mRNA)-based therapeutics for the treatment of various diseases becomes more and more important because of the positive properties of in vitro transcribed (IVT) mRNA. With the help of IVT mRNA, the de novo synthesis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07de456a58d6fe359559b9e28c1ab226
https://pubmed.ncbi.nlm.nih.gov/30774119
https://pubmed.ncbi.nlm.nih.gov/30774119
Autor:
Karlheinz Peter, Stefanie Krajewski, Meike-Kristin Abraham, Antonia Link, Christian Schlensak, Tatjana Michel, Xiaowei Wang, Hans Peter Wendel
Publikováno v:
Journal of Visualized Experiments.
The development of messenger RNA (mRNA)-based therapeutics for the treatment of various diseases becomes more and more important because of the positive properties of in vitro transcribed (IVT) mRNA. With the help of IVT mRNA, the de novo synthesis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90dabe43afb3f596cb17086a192926c6
https://doi.org/10.3791/58444-v
https://doi.org/10.3791/58444-v
P942Restoring of heart function after myocardial infarction using activated platelets targeted drugs
Autor:
Melanie Ziegler, Meike-Kristin Abraham, Harshal Hanumant Nandurkar, Karlheinz Peter, Xiaowei Wang, Amy Kate Searle, Jan David Hohmann
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4625778fa7a534e7771fa51eef2693c1
https://doi.org/10.1093/eurheartj/ehy564.p942
https://doi.org/10.1093/eurheartj/ehy564.p942